We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Naturopathic Compound Suppresses Growth of Prostate Cancer Cell Cultures

By LabMedica International staff writers
Posted on 19 Apr 2011
A recent paper by cancer researchers working with prostate cancer cell cultures supports claims of the efficacy of a naturopathic formulation as an anticancer treatment.

Investigators at Indiana University (Indianapolis, USA) evaluated the effects of the dietary supplement ProstaCaid (PC), which contains mycelium from medicinal mushrooms (Ganoderma lucidum, Coriolus versicolor, Phellinus linteus), saw palmetto berry, pomegranate, pumpkin seed, green tea [40% epigallocatechin-3-gallate (EGCG)], Japanese knotweed (50% resveratrol), extracts of turmeric root (BCM-95), grape skin, pygeum bark, sarsaparilla root, Scutellaria barbata, eleuthero root, Job's tears, astragalus root, skullcap, dandelion, coptis root, broccoli, and stinging nettle, with purified vitamin C, vitamin D3, selenium, quercetin, citrus bioflavonoid complex, beta-sitosterolzinc, lycopene, alpha lipoic acid, boron, berberine and 3.3'-diinodolymethane (DIM). More...
The ingredients form a collection of the natural products best known to be rich in anti-inflammatory and antioxidant activities.

In the current study, which was published in the April 4, 2011, online edition of the International Journal of Oncology, the investigators exposed cultures of prostate cancer cells to PC and then evaluated its effects on gene expression, tumor growth, and tumor invasiveness.

They reported that PC treatment inhibited cell proliferation in the population of highly invasive human hormone independent PC-3 prostate cancer cells in a dose- and time-dependent manner. PC suppressed the metastatic behavior of PC-3 cells by the inhibition of cell adhesion, cell migration, and cell invasion. DNA-microarray analysis demonstrated that PC inhibited proliferation through the modulation of expression of CCND1, CDK4, CDKN1A, E2F1, MAPK6, and PCNA genes.

Senior author Dr. Daniel Silva, associate professor of medicine at Indiana University, said, "The formula we studied has been shown to inhibit growth of human androgen dependent as well as independent prostate cancer cells, and suppresses the metastatic potential of these cells. We were able to identify specific genes, which are responsible for growth of human prostate cancer cells and show, on the molecular level, how it affects the cancer cells. Natural compounds in this formula are known to be without the side effects associated with traditional cancer chemotherapy drugs.”

Related Links:
Indiana University



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gel Cards
DG Gel Cards
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.